The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial.
 
Zhongyu Yuan
No Relationships to Disclose
 
Jia-Jia Huang
No Relationships to Disclose
 
Xin Hua
No Relationships to Disclose
 
Jian-Li Zhao
No Relationships to Disclose
 
Ying Lin
No Relationships to Disclose
 
Yuan-Qi Zhang
No Relationships to Disclose
 
Zhiyong Wu
No Relationships to Disclose
 
Lehong Zhang
No Relationships to Disclose
 
XiWen Bi
No Relationships to Disclose
 
Wen Xia
No Relationships to Disclose
 
Yong-yi Zhong
No Relationships to Disclose
 
Shu-Sen Wang
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Ruoxi Hong
No Relationships to Disclose
 
Kuikui Jiang
No Relationships to Disclose
 
Yanxia Shi
No Relationships to Disclose
 
Cong Xue
No Relationships to Disclose
 
Xin An
No Relationships to Disclose